2012Liaoning Zhongyiyao Daxue xuebaoRequires access

Clinical Study on Parkinson Disease with Depression Treated by Xiaoyao Powder

Lu Hui

Open publisher page 0 citations

Abstract

Objective:To investigate clinical effect on Parkinson disease with depression treated by xiaoyao powder.Methods:Treatment group and control group all take madopar(0.125~0.25g,three times a day)and Fluxetine capsule(20mg each time everyday)as the basic treatment.At the same time,treatment group add xiaoyao powder in the therapy.Results:Total effective rate in the treatment group was 90.7% and the controlgroup was 79.07%.By rank sum test,the difference of the both groups had statistical significance(U=2.019,P=0.0340.05).According to HAMD score,treatment group is obviously better than the control group in the both groups before and after treatment.Conclusion:Xiaoyao powder is effective in clinical treatment of Parkinson disease with depression.

About this research paper

What this paper is about

Objective:To investigate clinical effect on Parkinson disease with depression treated by xiaoyao powder.Methods:Treatment group and control group all take madopar(0.125~0.25g,three times a day)and Fluxetine capsule(20mg each time everyday)as the basic treatment.At the same time,treatment group add xiaoyao powder in the therapy.Results:Total effective rate in the treatment group was 90.7% and the controlgroup was 79.07%.By rank sum test,the difference of the both groups had statistical significance(U=2.019,P=0.0340.05).According to HAMD score,treatment group is obviously better than the control group in the both groups before and after treatment.Conclusion:Xiaoyao powder is effective in clinical treatment of Parkinson disease with depression.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To investigate clinical effect on Parkinson disease with depression treated by xiaoyao powder.Methods:Treatment group and control group all take madopar(0.125~0.25g,three times a day)and Fluxetine capsule(20mg each time everyday)as the basic treatment.At the same time,treatment group add xiaoyao powder in the therapy.Results:Total effective rate in the treatment group was 90.7% and the controlgroup was 79.07%.By rank sum test,the difference of the both groups had statistical significance(U=2.019,P=0.0340.05).According to HAMD score,treatment group is obviously better than the control group in the both groups before and after treatment.Conclusion:Xiaoyao powder is effective in clinical treatment of Parkinson disease with depression.

Key concepts: Medicine, Hamd, Depression (economics), Statistical significance, Parkinson's disease, Internal medicine, Disease, Significant difference

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical Study on Parkinson Disease with Depression Treated by Xiaoyao Powder — Research Paper | ScholarLens